Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6465626

COc1cc2nc(Nc3nc(O)c4cc(OCCN(C)CCO)ccc4n3)nc(C)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.39
MAPT P10636 8/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
HTT P42858 2/20 0.36
PSMD14 O00487 1/20 0.36
APAF1 O14727 1/20 0.36
MITF O75030 1/20 0.36
HPGD P15428 1/20 0.36
PTK2B Q14289 1/20 0.36
TP53 P04637 3/20 0.35
LMNA P02545 2/20 0.35
TDP2 O95551 1/20 0.35
USP2 O75604 1/20 0.35
RAB9A P51151 1/20 0.35
AURKA O14965 1/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6467438 0.93 FGFR2 (0.41) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6469711 0.92 RET (0.39) CSF1RMAPTMEN1KMT2AKDM4E
Trifluoroacetic Acid SCHEMBL6467465 0.91 MAPT (0.39) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6467347 0.91 FGFR2 (0.38) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6469701 0.90 KDM4E (0.35) CSF1RMAPTMEN1KMT2AKDM4E
Trifluoroacetic Acid SCHEMBL6467968 0.89 KDR (0.41) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6467884 0.88 MAPT (0.37) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6467995 0.88 FGFR2 (0.41) MAPTMEN1KMT2AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL6466263 0.88 MAPT (0.40) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL6468701 0.88 CSF1R (0.38) CSF1RMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB CSF1R 3573/4885MAPT 3552/4885MEN1 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.